It has been hypothesized that the dysfunction of insulin signaling in the brain may be one of the mechanisms that trigger the onset and progression of AD, leading some researchers to refer to AD as “type 3 diabetes mellitus” due to the parallels between the impaired brain insulin signaling observed in AD and the insulin resistance observed in T2DM [47]. The gene discussed is INS; the disease is type 2 diabetes mellitus.